معرفی
Kamila Kaminska is an Associate Researcher at the Lund University Cancer Centre (LUCC), specializing in cancer and oncology research with dual focus areas in breast cancer and melanoma. Her work contributes to UN Sustainable Development Goals related to health and wellbeing through her cancer research.
Her research interests span multiple areas of oncology including breast cancer, melanoma, endocrine therapy, fulvestrant resistance, immune checkpoint blockade, and CDK inhibitors. Her work focuses particularly on molecular mechanisms of therapy resistance and identifying novel treatment strategies for cancer patients.
Analysis of her publication record reveals a strong focus on understanding resistance mechanisms in cancer therapies. Her research spans both breast cancer (particularly hormone receptor-positive disease) and melanoma, with emphasis on molecular patterns that predict response or resistance to targeted therapies. Her work demonstrates sophisticated approaches to overcoming treatment resistance through combination therapies and biomarker identification.
Kaminska is actively involved in the Lund University Cancer Centre, participating in multiple conferences and workshops including the LUCC Skin Retreat and LUCC Imaging & Nuclear Medicine events. She frequently collaborates with researchers across Lund University on cancer-related projects.
